Cytokinetics, Incorporated
IT ˙ BIT ˙ US23282W6057
62,32 € 0,00 (0,00%)
2026-06-05
DEL PRIS
SecurityIT:1CYTK / Cytokinetics, Incorporated
InstitutionAmeriprise Financial Inc
Latest Disclosed Ownership302,802 shares
Latest Disclosed Value $ 19,957,681
Ameriprise Financial Inc ownership in 1CYTK / Cytokinetics, Incorporated

On May 15, 2026 - Ameriprise Financial Inc filed a 13F-HR form disclosing ownership of 302,802 shares of Cytokinetics, Incorporated (IT:1CYTK) valued at $16,351,308 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 545,805 shares of Cytokinetics, Incorporated. This represents a change in shares of -44.52% during the quarter. The current value of the position is $18,870,621 USD.

Ameriprise Financial Inc has a history of taking positions in derivatives of the underlying security (1CYTK) in the form of stock options. The firm currently holds call options representing 181,700 of underlying shares valued at $11,975,847 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

IT:1CYTK / Cytokinetics, Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F CYTOKINETICS COM 23282W605 302,802 -243,003 -44.52 19,958 -42.45 0.0009
2026-02-17 2025-12-31 13F CYTOKINETICS COM 23282W605 545,805 -18,742 -3.32 34,680 11.77 0.0078
2025-11-14 2025-09-30 13F CYTOKINETICS COM 23282W605 564,547 219,581 63.65 31,028 172.24 0.0071
2025-08-14 2025-06-30 13F CYTOKINETICS COM 23282W605 344,966 -441,617 -56.14 11,398 -63.95 0.0028
2025-05-14 2025-03-31 13F CYTOKINETICS COM 23282W605 786,583 34,182 4.54 31,612 -10.68 0.0085
2025-02-14 2024-12-31 13F CYTOKINETICS COM 23282W605 752,401 210,266 38.78 35,393 23.64 0.0091
2024-11-14 2024-09-30 13F CYTOKINETICS COM 23282W605 542,135 198,001 57.54 28,625 53.52 0.0073
2024-08-14 2024-06-30 13F CYTOKINETICS COM 23282W605 344,134 50,111 17.04 18,645 -9.55 0.0050
2024-05-15 2024-03-31 13F CYTOKINETICS COM 23282W605 294,023 -43,232 -12.82 20,614 -26.79 0.0057
2024-02-14 2023-12-31 13F CYTOKINETICS COM 23282W605 337,255 21,837 6.92 28,157 203.02 0.0084
2023-11-14 2023-09-30 13F CYTOKINETICS COM 23282W605 315,418 -29,650 -8.59 9,292 -17.45 0.0031
2023-08-14 2023-06-30 13F CYTOKINETICS COM 23282W605 345,068 -56,086 -13.98 11,256 -20.26 0.0035
2023-05-22 2023-03-31 13F/A-1 CYTOKINETICS COM 23282W605 401,154 -16,238 -3.89 14,117 -26.19 0.0046
2023-05-15 2023-03-31 13F CUTERA COM 23282W605 401,154 -16,238 14,117 0.0009
2023-02-14 2022-12-31 13F CYTOKINETICS COM 23282W605 417,392 -125,504 -23.12 19,125 -27.29 0.0066
2022-11-14 2022-09-30 13F CYTOKINETICS COM 23282W605 542,896 -18,446 -3.29 26,304 19.25 0.0097
2022-08-15 2022-06-30 13F CYTOKINETICS COM 23282W605 561,342 2,372 0.42 22,058 7.21 0.0077
2022-05-16 2022-03-31 13F CYTOKINETICS COM 23282W605 558,970 -612 -0.11 20,575 -19.33 0.0061
2022-02-14 2021-12-31 13F CYTOKINETICS COM 23282W605 559,582 206,147 58.33 25,506 101.90 0.0071
2021-11-15 2021-09-30 13F CYTOKINETICS COM 23282W605 353,435 38,413 12.19 12,633 102.61 0.0040
2021-08-16 2021-06-30 13F CYTOKINETICS COM 23282W605 315,022 -1,007 -0.32 6,235 -15.19 0.0019
2021-05-17 2021-03-31 13F CYTOKINETICS COM 23282W605 316,029 14,853 4.93 7,352 17.46 0.0024
2021-02-12 2020-12-31 13F CYTOKINETICS COM 23282W605 301,176 -11,447 -3.66 6,259 -7.51 0.0022
2020-11-16 2020-09-30 13F CYTOKINETICS COM 23282W605 312,623 37,063 13.45 6,767 4.19 0.0028
2020-08-14 2020-06-30 13F CYTOKINETICS COM 23282W605 275,560 -33,085 -10.72 6,495 78.48 0.0028
2020-05-15 2020-03-31 13F CYTOKINETICS COM 23282W605 308,645 -13,104 -4.07 3,639 6.62 0.0019
2020-02-14 2019-12-31 13F CYTOKINETICS COM 23282W605 321,749 3,714 1.17 3,413 -5.69 0.0014
2019-11-14 2019-09-30 13F CYTOKINETICS COM 23282W605 318,035 -4,525 -1.40 3,619 -0.28 0.0016
2019-08-14 2019-06-30 13F CYTOKINETICS COM 23282W605 322,560 11,210 3.60 3,629 44.07 0.0016
2019-05-15 2019-03-31 13F CYTOKINETICS COM 23282W605 311,350 5,965 1.95 2,519 30.52 0.0012
2019-02-14 2018-12-31 13F CYTOKINETICS COM 23282W605 305,385 -7,566 -2.42 1,930 -37.40 0.0010
2018-11-14 2018-09-30 13F CYTOKINETICS COM 23282W605 312,951 30,611 10.84 3,083 31.53 0.0011
2018-08-14 2018-06-30 13F CYTOKINETICS COM 23282W605 282,340 18,750 7.11 2,344 23.50 0.0010
2018-05-14 2018-03-31 13F CYTOKINETICS COM 23282W605 263,590 6,354 2.47 1,898 -9.45 0.0009
2018-02-12 2017-12-31 13F CYTOKINETICS COM 23282W605 257,236 -101,477 -28.29 2,096 -59.70 0.0010
2017-11-07 2017-09-30 13F CYTOKINETICS COM 23282W605 358,713 117,882 48.95 5,201 78.48 0.0025
2017-08-10 2017-06-30 13F CYTOKINETICS COM 23282W605 240,831 240,831 2,914 0.0015
2016-08-08 2016-06-30 13F CYTOKINETICS COM 23282W605 0 -182,791 -100.00 0 -100.00
2016-05-12 2016-03-31 13F CYTOKINETICS COM 23282W605 182,791 -11,388 -5.86 1,289 -36.53 0.0008
2016-02-11 2015-12-31 13F CYTOKINETICS COM 23282W605 194,179 194,179 0.00 2,031 0.0012
2015-11-12 2015-09-30 13F CYTOKINETICS COM 23282W605 0 -16,365 -100.00 0 -100.00
2015-08-13 2015-06-30 13F CYTOKINETICS COM 23282W605 16,365 16,365 0.00 110 0.0001
2015-02-13 2014-12-31 13F CYTOKINETICS COM 23282W605 0 -700 -100.00 0 -100.00
2014-11-14 2014-09-30 13F CYTOKINETICS COM 23282W605 700 0 0.00 2 -33.33 0.0000
2014-08-13 2014-06-30 13F CYTOKINETICS COM 23282W605 700 -954 -57.68 3 -76.92 0.0000
2013-11-14 2013-09-30 13F CYTOKINETICS COM 23282W605 1,654 110 7.12 13 -27.78 0.0000
2013-08-14 2013-06-30 13F CYTOKINETICS COM 23282W605 1,544 1,544 18 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F CYTOKINETICS OPT Call 181,700 11,976 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.